JHLT: The Podcast

JHLT: The Podcast

Download on the App Store

JHLT: The Podcast episodes

  • Episode 96: Could Durable LVADs be an Intentional First-Line Strategy?

    JHLT: The Podcast returns to the heart side this month with a State of the Art paper published earlier this year in JHLT and now available in the November print issue.

    First author Alexander M. Bernhardt, MD, ISHLTF, of the University Heart and Vascular Center in Hamburg Germany, joins the podcast to discuss "Net prolongation of life in advanced heart failure: An intentional strategy of durable LVAD therapy followed by heart transplantation."

    In their discussion, they cover:

    • Incorporating long-term consequences of transplantation into today's treatment decisions
    • Characteristics of patients that may be suited for this approach
    • Comparable outcomes in LVAD weaning
    • Upcoming studies and results that expand this idea beyond registry data

    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    11 min
  • Episode 95: Cytotoxic T Cells and Transcriptional Priming in Lung Transplantation

    Today's JHLT: The Podcast features a recent article on a pediatric cohort in JHLT: "Cytotoxic CD8+ T cells persist and show transcriptional priming in lung transplantation."

    Today's guest is senior author Don Hayes, Jr., MD, MS, Med, MBA, ISHLTF, of the Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine.

    The discussion with Dr. Hayes explores:

    • The fascinating behavior and persistence of CD8+ T-cell clones in the cohort
    • What we know—and don't know—about these cells' role in inflammation and allograft rejection
    • Therapeutic and clinical considerations for patients displaying these T-cells
    • The future of the research, including further validation, surveillance, and precision immunosuppression

    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    14 min
  • Episode 94: ISHLT Consensus: Frailty in Candidates for Lung Transplant

    JHLT: The Podcast continues its exploration of recent consensus documents this month by discussing "Assessing and Addressing Frailty in Candidates for Lung Transplantation: An ISHLT Consensus Statement."

    The statement appears online now at JHLT, and a helpful companion perspective piece from the authors can be read in your October print issue of the Journal.

    Today's guests are project leads Michaela Anderson, MD, MS, of the Hospital of the University of Pennsylvania, and Jonathan Singer, MD, MS, of the University of California San Francisco.

    In their discussion, they cover:

    • What real-world teams want to know about frailty and how their document enhances clinical capacity
    • How programs decide which tools to use to use to measure frailty—and which are most relevant to lung transplantation
    • The importance of—and best timing for—universal assessment
    • What's next in studying frailty

    Stay up to date with official standards and guidelines documents from ISHLT at ISHLT.org. For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    29 min
  • Episode 93: ISHLT Consensus Document: BLAD Definition, Timing, Outcomes

    Today, JHLT: The Podcast discusses the recent ISHLT consensus document "Baseline Lung Allograft Dysfunction: Definition, Timing, and Implications for Outcomes—An ISHLT Consensus Document."

    Now available online at JHLT—and a helpful companion perspective piece from the authors appears in the print October issue of JHLT.

    Today's guests are co-leads on the document, Jens Gottlieb, MD, of Hannover Medical School and Kieran Halloran, MD, MSc, of the University of Alberta.

    They discuss:

    • Why rapid increases in usage of "BLAD" in the literature meant it was time for a formal definition
    • Major considerations and areas of debate during the writing process
    • How clinicians should think about patients meeting the criteria for BLAD and how the evaluation of underlying etiologies took place
    • Interpreting BLAD's potential relationship to CLAD

    Stay up to date with official standards and guidelines documents from ISHLT at ISHLT.org. For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    34 min
  • Episode 92: Treating PPAS with Stent-Based Pulmonary Angioplasty

    In this episode, JHLT: The Podcast continues the Pulmonary Hypertension theme for the month, exploring the study "Long-Term outcomes of stent-based pulmonary angioplasty for isolated peripheral pulmonary artery stenosis," which appears in the September print issue of JHLT.

    Today's guest is author Hiroto Shimokawahara, MD, of the Okayama Medical Center in Japan.

    Dr. Shimokawahara's discussion with Digital Media Editor Van-Khue Ton covers:

    • What the study contributes to the clinical literature with longer-term outcomes of stent-based pulmonary angioplasty in peripheral pulmonary artery stenosis (PPAS)
    • How the diffuse nature of PPAS and the advanced stage of disease complicates treatment options
    • The evolution of stent choices and technologies in the last 20 years of clinical practice at their center
    • Ideal follow-up conditions for monitoring patients after PPAS stenting

    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    17 min
  • Episode 91: Medical Therapy Pre- and Post-Pulmonary Endarterectomy

    Today, JHLT: The Podcast discusses "Long-term effects of medical therapy pre- and post-pulmonary endarterectomy—insights from the UK CURATE registry," a manuscript available online now and in the September print issue of JHLT.

    Today's guest is first author Paula Appenzeller, MD, of the National Pulmonary Vascular Diseases Unit at Royal Papworth Hospital in Cambridge.

    In the episode, Dr. Appenzeller and the editors discuss:

    • How findings from the UK CURATE registry challenge assumptions about pre-operative therapy in CTEPH
    • What's important about the 6-minute walk distance test
    • How hemodynamics help guide post-PEA treatment decisions
    • If multimodal CTEPH treatment could become the norm

    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    14 min
  • Episode 90: The ASSIST CLAD Study: Using Mesenchymal Stromal Cells in New-Onset CLAD

    In this episode, JHLT: The Podcast explores the study "The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction," which appears in the August print issue of JHLT.

    Today's guest is Daniel C. Chambers, MBBS, MD, of The Prince Charles Hospital and Queensland Lung Transplant Service in Brisbane, Australia.

    From across the dateline, he and Digital Media Editor Erika Lease discuss:

    • What inspired the team to explore the use of mesenchymal stromal cell (MSC) infusions in CLAD patients
    • Preparation and treatment considerations for using MSCs
    • How despite the negative outcome—the MSCs made no clear improvements in the patient groups—the study still pushes the field forward

    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    12 min
  • Episode 89: Improved Outcomes and Utilization in Hearts With 10° Static Cold Storage

    Today, JHLT: The Podcast discusses "Improved outcomes and donor utilization in heart transplantation with 10 °C static cold storage," a manuscript available online now and in the August print issue of JHLT.

    Today's guest is senior author John Trahanas, MD, of the Vanderbilt University School of Medicine in Nashville, TN USA.

    In the episode, Dr. Trahanas and the editors discuss:

    • What was learned from the lung 10°C trials and how the team adapted the devices for hearts
    • The improved outcomes in PGD and survivability observed in the 10°C group
    • How to determine if switching from ice to 10°C actually changed donor selection practices—and how it enabled the team to use more hearts

    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    15 min
  • Episode 88: Looking Back: Is Sotatercept Safe in Patients with PAH?

    In case you missed it, JHLT: The Podcast is re-releasing a past audience favorite for your listening pleasure. This month, we revisit a conversation regarding a study from the April 2025 issue of JHLT about the efficacy and safety of sotatercept in patients with PAH.

    This conversation with Ioana Preston, MD, of the Tufts University School of Medicine in Boston, explores:

    • What makes sotatercept unique as the first "biologic" in the treatment of PAH
    • Hypotheses about the mechanism of action in sotatercept
    • Sotatercept's interaction with mPAP and what it indicates about the drug's action on the pulmonary vasculature

    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    13 min
  • Episode 87: The Trifecta Heart Study: Assessing Donor Specific Antibodies in AMR

    JHLT: The Podcast returns for July with a paper entitled "Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study," available online now and in the July print issue of JHLT.

    Today's guests are first author Katelynn S. Madill-Thomsen, PhD and senior author Philip F. Halloran, MD, PhD, both from the Alberta Transplant Applied Genomics Center in Canada.

    In the episode, the authors and editors discuss:

    • Striking similarities—and key differences—in the DSA-negative and DSA-positive groups
    • Changes to clinical practice based on the findings, including innovations from the kidney transplant community
    • Future studies, including tools and therapies that could be explored for improved clinical outcomes

    For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    19 min

About JHLT: The Podcast

From the publisher's feed

The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.

More shows like JHLT: The Podcast

This American Life by This American Life

This American Life

90,458 Listeners

Freakonomics Radio by Freakonomics Radio + Stitcher

Freakonomics Radio

31,956 Listeners

JAMA Editors' Summary by JAMA Network

JAMA Editors' Summary

133 Listeners

NEJM This Week by NEJM Group

NEJM This Week

322 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

496 Listeners

JACC This Week by American College of Cardiology

JACC This Week

163 Listeners

This Week in Cardiology by Medscape

This Week in Cardiology

892 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,425 Listeners

The Daily by The New York Times

The Daily

112,285 Listeners

Up First from NPR by NPR

Up First from NPR

61,528 Listeners

Eagle's Eye View: Your Weekly CV Update From ACC.org by American College of Cardiology

Eagle's Eye View: Your Weekly CV Update From ACC.org

135 Listeners

JAMA Medical News by JAMA Network

JAMA Medical News

95 Listeners

Cardionerds: A Cardiology Podcast by CardioNerds

Cardionerds: A Cardiology Podcast

438 Listeners

Heart Failure Beat by Heart Failure Society of America

Heart Failure Beat

19 Listeners

Good Hang with Amy Poehler by The Ringer

Good Hang with Amy Poehler

12,349 Listeners